To investigate the molecular mechanisms underlying this phenotypic switch, the activation status of NF-κB and JAK/STAT signaling pathways, typically activated in acute inflammation and involved in the exacerbation of host inflammatory responses in COVID-19 patients [21], was then assessed. The gene discussed is NFKB1; the disease is COVID-19.